Brief: Mersana Therapeutics Q1 collaboration revenue USD 7.802 million
09/05/2023 13:21
May 9 (Reuters) - Mersana Therapeutics Q1 net income USD -56.163 million. * Q1 collaboration revenue USD 7.802 million
MRSN — Mersana Therapeutics News Story
0.000.00%
Last trade - 00:00- $145.16m
- $88.77m
- $40.50m